09:50 AM EST - Fennec Pharmaceuticals Inc. : Announced that Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, has commercially launched PEDMARQSI (sodium thiosulfate injection) in Germany. Fennec Pharmaceuticals Inc.
shares T.FRX are trading unchanged at $9.49.
